Johnson & Johnson’s COVID-19 vaccine may not be as effective as those using mRNA technology, according to a new study Tuesday. The study published by bioRxiv says the 13 million …
AstraZeneca said Monday that advanced study data from a U.S. study on its vaccine shows it is 79% effective at preventing symptomatic COVID-19 and 100% effective at halting serious illness …
As schools re-open across the country, there’s one thing that has not gone away: lockdown drills All of Van Duyn Elementary School in Syracuse, New York, went eerily quiet. On …
Another COVID-19 vaccine is about to go on sale – a single vaccine from Johnson & Johnson’s pharmaceutical subsidiary Janssen. The company just released an efficacy report based on data …